CCM
WST icon

Cinctive Capital Management’s West Pharmaceutical WST Stock Holding History

Cinctive Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
+7,604
New +$2.32M 0.1% 244
2026
Q1 		– Sell
-1,350
Closed -$371K – 527
2025
Q4 		$371K Sell
1,350
-12,969
-91% -$3.55M 0.02% 345
2025
Q3 		$3.76M Buy
+14,319
New +$3.48M 0.18% 179
2025
Q2 		– Sell
-5,140
Closed -$1.15M – 479
2025
Q1 		$1.15M Sell
5,140
-10,911
-68% -$3.01M 0.09% 202
2024
Q4 		$5.26M Buy
+16,051
New +$5.05M 0.27% 127
2024
Q1 		– Sell
-4,013
Closed -$1.41M – 521
2023
Q4 		$1.41M Sell
4,013
-28,698
-88% -$10.2M 0.09% 214
2023
Q3 		$12.3M Buy
32,711
+4,518
+16% +$1.75M 0.61% 43
2023
Q2 		$10.8M Buy
28,193
+10,098
+56% +$3.61M 0.36% 83
2023
Q1 		$6.27M Buy
18,095
+12,132
+203% +$3.54M 0.21% 172
2022
Q4 		$1.4M Buy
+5,963
New +$1.41M 0.07% 288

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cinctive Capital Management's WST Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 7,604 shares worth $2.73M. The stake represents 0.1% of the portfolio and ranks #244 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in WST as recently as Q4 2025.

Cinctive Capital Management first reported a position in WST in Q4 2022 and has held it in 10 quarters since. The position peaked at $12.3M in Q3 2023. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cinctive Capital Management held 7,604 shares of West Pharmaceutical worth $2.73M as of Q2 2026.
  • West Pharmaceutical was a new Cinctive Capital Management position in Q2 2026.
  • West Pharmaceutical made up 0.1% of Cinctive Capital Management's portfolio in Q2 2026, its #244 holding.
  • Cinctive Capital Management first reported a position in West Pharmaceutical in Q4 2022 and has held it in 10 quarters since.
  • Cinctive Capital Management's West Pharmaceutical position peaked at $12.3M in Q3 2023.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.